BiotechTube
Home/Polaris Pharma/Maureen Liu, MSc
ML

Maureen Liu, MSc

Director, Clinical Development

Polaris Pharma

Therapeutic Areas

OncologyMetabolic Disease

Polaris Pharma Pipeline

DrugIndicationPhase
ADI-PEG 20 (pegargiminase)Malignant Pleural Mesothelioma (Non-epithelioid)Phase 3 / BLA

Leadership Team at Polaris Pharma

SC
Samuel Chen
Chairman & Chief Executive Officer
JB
John Bomalaski, M.D.
Executive Vice President, Medical Affairs
AJ
Amanda Johnston, Ph.D.
Senior Vice President, Clinical Affairs
CH
Chris Huxsoll, Ph.D.
Senior Vice President, Operations
View full Polaris Pharma profile